Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial

Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register

(2012) Marieke H Otten et al.   ANNALS OF THE RHEUMATIC DISEASES

Systematic Review of Tocilizumab for Rheumatoid Arthritis: A New Biologic Agent Targeting the Interleukin-6 Receptor

(2012) Iris Navarro-Millán et al.   CLINICAL THERAPEUTICS

Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

(2012) Fabrizio De Benedetti et al.   NEW ENGLAND JOURNAL OF MEDICINE

Networking in paediatrics: the example of the Paediatric Rheumatology International Trials Organisation (PRINTO)

(2011) Nicolino Ruperto et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Cholesterol Curves to Identify Population Norms by Age and Sex in Healthy Weight Children

(2011) Asheley Cockrell Skinner et al.   CLINICAL PEDIATRICS

Juvenile idiopathic arthritis

(2011) Berent Prakken et al.   LANCET

Integrated safety in tocilizumab clinical trials

(2011) Michael H Schiff et al.   ARTHRITIS RESEARCH & THERAPY

Is it time to move to active comparator trials in juvenile idiopathic arthritis?: A review of current study designs

(2010) Nicolino Ruperto et al.   ARTHRITIS AND RHEUMATISM

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

(2008) Nicolino Ruperto et al.   LANCET

Lipid Screening and Cardiovascular Health in Childhood

(2008) S. R. Daniels et al.   PEDIATRICS